We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

OSI-906 and Irinotecan in Patients With Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01016860
Recruitment Status : Terminated (This study was discontinued due to a shown lack of efficacy in the investigational agent)
First Posted : November 20, 2009
Last Update Posted : October 21, 2013
Information provided by (Responsible Party):
University of Colorado, Denver